Меню
Набор скоро начнётся NCT07710677

Investigating the Neurophysiology of the Motor System and the Feasibility of Vagus Nerve Stimulation in Functional Neurological Disorder (FND)

Без фазы С лечением Functional Neurological Disorder Motor Symptoms

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Vagial Nerve Stimulation (VNS) active stimulation, Vagial Nerve Stimulation (VNS) sham stimulation.
Кому может быть актуально
Состояния в реестре: Functional Neurological Disorder, Motor Symptoms. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Швейцария
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Investigating the Neurophysiology of the Motor System and the Feasibility of Vagus Nerve Stimulation in Functional Neurological Disorder (FND): a Randomized, Sham-controlled Study

Обзор

This clinical study will test if adding a non-invasive stimulation of the vagus nerve through the ear during physiotherapy brings an improvement to FND (Functional Neurological Disorder) patients with motor symptoms. First, the investigators will test the normal functioning of the motor regions of the brain in FND patients and in healthy volunteers for comparison, using a painless method called TMS (Transcranial Magnetic Stimulation). Then, the investigators will further test how brain regions communicate with each other in FND patients, using fMRI (functional Magnetic Resonance Imaging, also painless). Additionally, the investigators will ask both FND patients and healthy volunteers to answer questions about their health and wellbeing, and will assess the exact symptoms of FND patients. The FND patients will then be assigned to two groups randomly, and neither they nor the researchers will know in which group they are. Both groups will do 5 sessions of their usual physiotherapy - one group with a real stimulation of the vagus nerve, and the other group with a fake stimulation. This is important to obtain reliable results. At the end, both groups of patients will be tested again to see if the way brain regions communicate with each other has changed. They will also answer again questions about their health and wellbeing, and their symptoms will be assessed again, to see if any changes happen. The results of the two groups of patients will be compared to isolate the effects of vagus nerve stimulation from the effects of physiotherapy alone.

Подробное описание

The main goal of this project is to better understand the neurophysiology of the motor system and the role of attention in Functional Neurological Disorder (FND) and to explore the physiological effects of a novel non-invasive treatment option for this disorder.

To this end, several methods will be employed: non-invasive brain stimulation (using Transcranial Magnetic Stimulation, TMS), neuroimaging (fMRI), transdermal auricular vagus nerve stimulation (taVNS), clinical assessments and questionnaires.

The study consists of 2 experiments, each with specific objectives.

Primary objective:

The primary objective of this study is to assess the effects of taVNS, as an adjunctive intervention to standard physical therapy, on the quality of life in FND patients.

Secondary objectives:

Experiment 1

1. Assess baseline neurophysiological differences of the motor system at rest and under different attentional demands, between FND patients and healthy participants. 2. Compare the motor behaviour of the upper limb (index finger) under different attentional demands, in FND patients and healthy participants. 3. Explore the role of symptom severity, mood, physical health, and interoception (the perception of bodily signals), assessed by questionnaires, in the modulation of motor system neurophysiology in FND patients and healthy participants. 4. Explore the relationship between neurophysiological (point 1) and behavioral (point 2) outcomes, and the outcomes of clinical and psychological scores measured (point 3).

Experiment 2

1. Assess the feasibility of the taVNS intervention as an adjunctive treatment in FND. 2. Determine whether adding taVNS to standard physical therapy improves clinical outcomes (motor symptoms) in FND patients, assessed by clinical scores (CGI, sFMDRS). 3. Explore changes in self-reported measures of mood, stress, physical health and interoception (the perception of bodily signals), assessed by questionnaires, after taVNS in FND patients. 4. Explore changes in upper limb strength, measured by a grip strength test with hand-held dynamometer under different starting conditions (pressing freely and pressing after a cue), before, during and after taVNS in FND. 5. Assess the effect of taVNS on heart rate and heart rate variability (HRV) in FND patients. 6. Analyse the modulation of brain network connectivity via fMRI at rest and during a behavioural task (emotion-motion task), before and after taVNS in FND patients. 7. Explore the relationship between neuroimaging (point 6), behavioral (point 2) outcomes, and the outcomes of clinical and psychological scores measured (point 3).

An additional outcome will explore the relationship between the outcomes of Experiment 1 and Experiment 2 to assess the prognostic potential of the outcomes of Experiment 1.

Вмешательства

  • Устройство Vagial Nerve Stimulation (VNS) active stimulation
    taVNS sends gentle electric stimuli to the vagus nerve branch located in the outer ear, which are transmitted to the nucleus of the solitary tract in the brainstem, and from there to the rest of the brain. The electrode site is the cymba conchae in in the outer ear. VNS thus acts to enhance the activity of the parasympathetic nervous system.
  • Устройство Vagial Nerve Stimulation (VNS) sham stimulation
    taVNS sends gentle electric stimuli for several minutes, during which time the patient will feel a tickling sensation. Then, for the rest of the session, the hidden device will be switched off (there will be no stimulation).

Первичные конечные точки

  • Self-reported quality of life [Срок оценки: For each intervention session at weeks 3, 4, 5, 6, 7]
Вторичные конечные точки (12)
  • Neurophysiology investigation of the pathology by comparing Motor-Evoked Potential between FND patients and healthy participant [Срок оценки: At TMS session, week 2 for patients and week 0 for heathy controls]
  • Neurophysiology investigation of the pathology by comparing resting motor threshold between FND patients and healthy participant [Срок оценки: At TMS session, week 2 for patients and week 0 for heathy controls]
  • Comparison of motor performance between patients and healthy controls [Срок оценки: At TMS session, week 2 for patients and week 0 for heathy controls]
  • Satisfaction rating of patients on the intervention [Срок оценки: At the end of the last intervention session at week 7]
  • Changes in upper limb strength, measured by a grip strength test under different starting conditions, before, during and after taVNS intervention. [Срок оценки: weeks 2, 3, 4, 5, 6, 7]
  • Changes in parasympathetic tone measured by heart rate variability [Срок оценки: During intervention sessions at weeks 3, 4, 5, 6, 7]
  • Change in functional connectivity, measured by resting-state fMRI [Срок оценки: weeks 0, 8]
  • General heath condition questionnaire [Срок оценки: week 0]
  • Study the evolution of symptom severity score [Срок оценки: weeks 1, 2, 3, 4, 5, 6, 7, 8]
  • Study evolution of perceived stress [Срок оценки: weeks 1, 2, 3, 4, 5, 6, 7, 8]
  • Study the evolution of the clinical global impression score [Срок оценки: weeks 1, 2, 3, 4, 5, 6, 7, 8]
  • Study the evolution of depression evaluation [Срок оценки: weeks 2, 8]

Критерии участия

Inclusion Criteria for FND patients:

  • Over 18 years of age.
  • Capable of judgement.
  • Willing to participate in the study (by signing the informed consent form).
  • FND diagnosis by a certified neurologist or psychiatrist.
  • Motor FND symptoms in the upper limb in the form of tremor or weakness.
  • Participating in physiotherapy for FND.

Exclusion Criteria for FND patients:

  • Severe neuropsychiatric comorbidities.
  • Pregnancy or breastfeeding.
  • Prior knowledge on the effects of attention on the motor system.
  • Prior history of epilepsy or epileptic seizures in the person and their family.
  • Severe claustrophobia.
  • Implanted medical devices.
  • Ear anatomy incompatible with the taVNS device (e.g. cauliflower ear).
  • Previous use of taVNS.
  • Substance abuse.
  • Simultaneous participation in another investigation involving an investigational drug or a MD.
  • Enrolment of the PI and their dependent persons.

Inclusion Criteria for healthy volunteers:

  • Over 18 years of age.
  • Capable of judgement.
  • Willing to participate in the study (by signing the informed consent form).

Exclusion Criteria for healthy volunteers:

  • Neurological or neuropsychiatric or movement disorders.
  • Pregnancy or breastfeeding.
  • Prior knowledge on the effects of attention on the motor system.
  • Prior history of epilepsy or epileptic seizures in the person and their family.
  • Substance abuse.
  • Simultaneous participation in another investigation involving an investigational drug or a MD.
  • Enrolment of the PI and their dependent persons.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Рандомизированное
Модель
Факторный дизайн
Маскирование
Двойное слепое
Основная цель
Поддерживающая терапия

Центры проведения

Швейцария · 1 центр
  • University of Fribourg — Fribourg

Идентификаторы

NCT: NCT07710677 · 2026-D0047

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗